Albemarle ( NYSE:ALB – Free Report ) had its price target decreased by Wells Fargo & Company from $270.00 to $260.00 in a research note released on Friday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the specialty chemicals company's stock. Several other brokerages have also recently issued reports on ALB. BMO Capital Markets lowered their price objective on shares of Albemarle from $325.00 to $300.00 in a research note on Friday, May 5th. UBS Group raised shares of Albemarle from a neutral rating to a buy rating and lifted their price objective for the stock from $196.

https://www.dailypolitical.com/2023/08/05/albemarle-nysealb-price-target-lowered-to-260-00-at-wells-fargo-company.html

#dailypolitical